Targeted therapies: Remembrance of things past - discontinuation of second-generation TKI therapy for CML.

Hughes, Timothy P

Targeted therapies: Remembrance of things past - discontinuation of second-generation TKI therapy for CML. [electronic resource] - Nature reviews. Clinical oncology 04 2017 - 201-202 p. digital

Publication Type: Journal Article; Comment

1759-4782

10.1038/nrclinonc.2017.11 doi


Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein Kinase Inhibitors